41O Nine weeks vs 1-year adjuvant trastuzumab: Long term outcomes of the ShortHER randomised trial
Titel:
41O Nine weeks vs 1-year adjuvant trastuzumab: Long term outcomes of the ShortHER randomised trial
Auteur:
Conte, P.F. Frassoldati, A. Bisagni, G. Brandes, A.A. Donadio, M. Garrone, O. Piacentini, F. Cavanna, L. Giotta, F. Aieta, M. Gebbia, V. Musolino, A. Ferro, A. Danese, S. Zamagni, C. Nanni, O. Dieci, M.V. Vicini, R. Balduzzi, S. Guarneri, V.